Review Articles
21. Myelodysplastic syndromes.
- Author
- Nimer SD;
- Institution
- Division of Hematologic Oncology and Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
- Journal
- Blood. 2008 May 15;111(10):4841-51.
- Abstract URL
- Click here to view abstract
22. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology.
- Author
- Disperati P; Ichim CV; Tkachuk D; Chun K; Schuh AC; Wells RA;
- Institution
- Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, Ont., Canada.
- Journal
- Leuk Res. 2006 Feb;30(2):233-9. Epub 2005 Jul 25.
- Abstract URL
- Click here to view abstract
23. Transfusion independence in patients with myelodysplastic syndromes: impact on outcomes and quality of life.
- Author
- Balducci L;
- Institution
- Department of Interdisciplinary Oncology, Geriatric Section, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497, USA. balducci@moffitt.usf.edu
- Journal
- Cancer. 2006 May 15;106(10):2087-94.
- Abstract URL
- Click here to view abstract
24. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
- Author
- de Lima M; Giralt S;
- Institution
- Department of Blood and Marrow Transplantation, M.D. Anderson Cancer Center, Houston, TX 77033, USA. mdelima@mdanderson.org
- Journal
- Semin Hematol. 2006 Apr;43(2):107-17.
- Abstract URL
- Click here to view abstract
25. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
- Author
- Nimer SD; Nimer SD;
- Institution
- Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021-6007, USA. s-nimer@mskcc.org
- Journal
- J Clin Oncol. 2006 Jun 1;24(16):2576-82.
- Abstract URL
- Click here to view abstract
26. Myelodysplasia: when to treat and how.
- Author
- Larson RA;
- Institution
- Department of Medicine and Cancer Research Center, University of Chicago Pritzker School of Medicine, MC-2115, 5841 S. Maryland Avenue, Chicago, IL 60637, USA. rlarson@medicine.bsd.uchicago.edu
- Journal
- Best Pract Res Clin Haematol. 2006;19(2):293-300.
- Abstract URL
- Click here to view abstract
27. The myelodysplastic syndromes: diagnosis and treatment.
- Author
- Steensma DP; Bennett JM; Steensma DP; Bennett JM;
- Institution
- Division of Hematology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA. steensma.david@mayo.edu
- Journal
- Mayo Clin Proc. 2006 Jan;81(1):104-30.
- Abstract URL
- Click here to view abstract
28. 5-azacytidine and decitabine monotherapies of myelodysplastic disorders.
- Author
- Kuykendall JR;
- Institution
- Department of Biomedical and Pharmaceutical Sciences, Raabe College of Pharmacy, Ohio Northern University, Ada, OH 45810-1599, USA. j-kuykendall@onu.edu
- Journal
- Ann Pharmacother. 2005 Oct;39(10):1700-9. Epub 2005 Sep 6.
- Abstract URL
- Click here to view abstract
29. Strategies for biology- and molecular-based treatment of myelodysplastic syndromes.
- Author
- Lindberg EH;
- Institution
- Karolinska Institutet, Dept of Medicine, Div of Hematology, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden. eva.hellstrom-lindberg@medhs.ki.se
- Journal
- Curr Drug Targets. 2005 Sep;6(6):713-25.
- Abstract URL
- Click here to view abstract
30. New agents in the treatment of childhood leukemias and myelodysplastic syndromes.
- Author
- Corey SJ;
- Institution
- Section of Pediatric Leukemia and Lymphoma, Division of Pediatrics and Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Box 853, 1515 Holcombe Boulevard, Houston, TX 77030, USA. sjcorey@mdanderson.org
- Journal
- Curr Oncol Rep. 2005 Nov;7(6):399-405.
- Abstract URL
- Click here to view abstract
Previous Section
